Page last updated: 2024-09-05

calystegine a3 and Gaucher Disease

calystegine a3 has been researched along with Gaucher Disease in 1 studies

*Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, I; Hirono, S; Kato, A; Koike, Y; Nakagawa, S; Nakagome, I; Nash, RJ1

Other Studies

1 other study(ies) available for calystegine a3 and Gaucher Disease

ArticleYear
Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease.
    Bioorganic & medicinal chemistry, 2014, Apr-15, Volume: 22, Issue:8

    Topics: Binding Sites; Catalytic Domain; Cell Line; Gaucher Disease; Glucosylceramidase; Humans; Hydrogen Bonding; Imino Pyranoses; Isomerism; Molecular Docking Simulation; Nortropanes; Solanaceous Alkaloids; Static Electricity; Structure-Activity Relationship; Tropanes

2014